Pyruvate-enriched resuscitation protects hindlimb muscle from ischemia-reperfusion injury

Military Medicine

Volumn 175, Issue 12, 2010, Pages 1020-1026

  Flaherty, Devin C ^a,b   Hoxha, Besim ^a,b   Sun, Jie ^a   Gurji, Hunaid ^a,b   Simecka, Jerry W ^a   Olivencia Yurvati, Albert H ^a,b   Mallet, Robert T ^a,b  

^a University of North   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTONIC SOLUTION; PYRUVIC ACID; RINGER'S LACTATE;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; FLUID THERAPY; GOAT; HINDLIMB; MALE; METABOLISM; REPERFUSION; REPERFUSION INJURY; SKELETAL MUSCLE;

ANIMALS; FLUID THERAPY; GOATS; HINDLIMB; ISOTONIC SOLUTIONS; MALE; MUSCLE, SKELETAL; PYRUVIC ACID; REPERFUSION; REPERFUSION INJURY;

EID: 78650331958     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-10-00097     Document Type: Article

References (36)

1. Clifford CC: Treating traumatic bleeding in a combat setting. Mil Med 2004;169:8-10.
2. Hatoko M, Tanaka A, Kuwahara M, Yurugi S, Iioka H, Niitsuma K: Differences of molecular response to ischemia-reperfusion of rat skeletal muscle as a function of ischemic time: study of the expression of p53, p21 WAF-1, Bax protein, and apoptosis. Ann Plast Surg 2002;48:68-74.
3. Kauvar DS, Baer DG, Dubick MA, Walters TJ: Effect of fluid resuscitation on acute skeletal muscle ischemia-reperfusion injury after hemorrhagic shock in rats. J Am Coll Surg 2006;202:888-96.
4. Pang CY: Ischemia-induced reperfusion injury in muscle flaps: pathogenesis and major source of free radicals. J Reconstr Microsurg 1990;6:77-83.
5. Savage SA, Fitzpatrick CM, Kashyap VS, Clouse WD, Kerby JD: Endothelial dysfunction after lactated Ringer's solution resuscitation for hemorrhagic shock. J Trauma 2005;59:284-90.
6. Manukhina EB, Downey HF, Mallet RT: Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Exp Biol Med 2006;231:343-65.
7. Pope A, French G, Longenecker DE (editors): Fluid resuscitation In: State of the Science for Treating Combat Casualties and Civilian Injuries, pp. 51-59 and 84-87. Washington, DC, National Academies Press, 1999.
8. Eefting F, Rensing B, Wigman J, et al: Role of apoptosis in reperfusion injury. Cardiovasc Res 2004;61:414-26.
9. Deb S, Sun L, Martin B, et al: Lactated Ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 2000;49:47-55.
10. Jaskille A, Alam HB, Rhee P, Hanes W, Kirkpatrick JR, Koustova E: D-lactate increases pulmonary apoptosis by restricting phosphorylation of bad and eNOS in a rat model of hemorrhagic shock. J Trauma 2004;57:262-70.
11. Mallet RT, Sun J, Knott EM, Sharma AB, Olivencia-Yurvati AH: Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med 2005;230:435-43.
12. Mallet RT, Squires JE, Bhatia S, Sun J: Pyruvate restores contractile function and antioxidant defenses of hydrogen peroxide-challenged myocardium. J Mol Cell Cardiol 2002;34:1173-84.
13. Mallet RT: Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med 2000;223:136-48.
14. Flaherty DC, Hoxha B, Sun J, et al: Pyruvate-fortified fluid resuscitation improves hemodynamic stability while suppressing systemic inflammation and myocardial oxidative stress after hemorrhagic shock. Mil Med 2010;175:166-72.
15. Flaherty DC, Hoxha B, Nelson S, et al: Peri-and intra-operative management of the goat during acute surgical experimentation. Lab Anim 2010;39:80-5.
16. Sharma AB, Knott EM, Bi J, Martinez RR, Sun J, Mallet RT: Pyruvate improves cardiac electromechanical and metabolic recovery from cardiopulmonary arrest and resuscitation. Resuscitation 2005;66:71-81.
17. Bergmeyer HU: Methods of Enzymatic Analysis, Vol. VI, pp. 570-577 and 582-592. New York, Academic Press, 1983.
18. Stuewe SR, Gwirtz PA, Agarwal N, Mallet RT: Exercise training enhances glycolytic and oxidative enxymes in canine ventricular myocardium. J Mol Cell Cardiol 2000;32:903-13.
19. Amé JC, Rolli V, Schreiber V, et al: PARP-2, a novel mammalian DNA-dependent poly (ADP-ribose) polymerase. J Biol Chem 1999;274:17860-8.
20. Szabo C: Poly (ADP-ribose) polymerase activation by reactive nitrogen species: relevance for the pathogenesis of inflammation. Nitric Oxide 2006;14:169-79.
21. Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA: Ischemia/reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle. J Orthop Res 2008;26:351-6.
22. Cowled PA, Leonardos L, Millard SH, Fitridge RA: Apoptotic cell death makes a minor contribution to reperfusion injury in skeletal muscle in the rat. Eur J Vasc Endovasc Surg 2001;21:28-34.
23. Koustova E, Rhee P, Hancock T, et al: Ketone and pyruvate Ringer's solutions decrease pulmonary apoptosis in a rat model of severe hemorrhagic shock and resuscitation. Surgery 2003;134:267-74.
24. Deb S, Martin B, Sun L, et al: Resuscitation with lactated Ringer's solution in rats with hemorrhagic shock induces immediate apoptosis. J Trauma 1999;46:582-8.
25. Jaskille A, Koustova E, Rhee P, et al: Hepatic apoptosis after hemorrhagic shock in rats can be reduced through modifications of conventional Ringer's solution. J Am Coll Surg 2005;202:25-35.
26. Mongan PD, Capacchione J, West S, et al: Pyruvate improves redox status and decreases indicators of hepatic apoptosis during hemorrhagic shock in swine. Am J Physiol Heart Circ Physiol 2002;283: H1634-44.
27. Mongan PD, Karaian J, Van der Schuur BM, Via DK, Sharma P: Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J Surg Res 2003;112:180-8.
28. Sharma P, Walsh KT, Kerr-Knott KA, Karaian JE, Mongan PD: Pyruvate modulates hepatic mitochondrial functions and reduces apoptosis indicators during hemorrhagic shock in rats. Anesthesiology 2005;103:65-73.
29. Lee YJ, Kang IJ, Bünger R, Kang YH: Mechanisms of pyruvate inhibition of oxidant-induced apoptosis in human endothelial cells. Microvasc Res 2003;66:91-101.
30. Kerr PM, Suleiman MS, Halestrap AP: Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol Heart Circ Physiol 1999;267: H496-502.
31. Duriez PJ, Shah GM: Cleavage of poly (ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 1997;75:337-49.
32. Knott EM, Ryou M-G, Sun J, et al: Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium. Am J Physiol Heart Circ Physiol 2005;289: H1123-30.
33. Tejero-Taldo MI, Caffrey JL, Sun J, Mallet RT: Antioxidant properties of pyruvate mediate its potentiation of β-adrenergic inotropism in stunned myocardium. J Mol Cell Cardiol 1999;31:1863-72.
34. Bassenge E, Sommer O, Schwemmer M, Bünger R: Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000;279: H2431-8.
35. Bünger R, Mallet RT, Hartman DA: Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Eur J Biochem 1989;180:221-33.
36. 2+ signals produced by osmotic stress in mouse skeletal muscle fibers. J Physiol 2008;586:197-210.